Recent research shows that women who start the most common type of hormone therapy — estrogen plus progestin — soon after menopause have a significantly higher risk of breast cancer than those who take the hormones later or not at all. James Simon, M.D., clinical professor of Obstetrics and Gynecology in the School of Medicine and Health Sciences, says estrogen promotes the growth of almost everything, including undetectable tumors in the breasts.
Considering Hormone Replacement Therapy?
Latest News
Members of the George Washington University (GW) School of Medicine and Health Sciences Physician Assistant (PA) Class of 2026 gathered for PA Match, when they learned where they will start the clinical phase of their health care training.
GW SMHS MD Program Class of 2025 gathered in Lisner Auditorium, where their medical school journeys first started four years earlier, to lear where they will go for residency training at the annual National Residency Matching Program Match Day, March 21.
A basket clinical trial focused on a pair of rare mitochondrial diseases, MELAS and LHON-Plus, is led by Anne Chiaramello, PhD, professor of anatomy and cell biology at GW SMHS, is now registration on ClinicalTrials.gov.